Tao Tian1, Xiangyang Fu2, Liangliang Hu1, Xiaofeng Yang1, Peng Sun1, Fengfeng Sun1. 1. Department of Urology, Zaozhuang Municipal Hospital, Zaozhuang, 277100, Shandong, People's Republic of China. 2. Zaozhuang Yicheng District People's Hospital, Zaozhuang, Shandong, 277300, People's Republic of China.
Abstract
PURPOSE: Renal carcinoma (RC) originates in the renal tubular epithelial system, among which renal cell carcinoma (RCC) is the most frequent one. The forkhead activin signal transducer 1 (FAST1) has been shown to interfere with tumor progression as an oncogene, while its role in RC is limited. Therefore, this paper explored the prognostic significance, specific effects, and related mechanisms of FAST1 on RC. PATIENTS AND METHODS: Cell colony formation assay, cell counting kit-8 (CCK8) assay, flow cytometry and Transwell assay were used to test cell proliferation, viability, apoptosis, migration and invasion, respectively. Western blot (WB) was employed to determine the protein level of FAST1. RESULTS: Our study confirmed that FAST1 was up-regulated in RC tissues and cell lines, and its overexpression often represented a poor prognosis of RC patients. Meanwhile, the in vitro experiments showed that overexpressing FAST1 facilitated RC cell viability, proliferation, migration, invasion and epithelial-mesenchymal transition (EMT), and repressed cell apoptosis. In addition, the in vivo experiments illustrated that the up-regulation of FAST1 strengthened tumor growth. On the contrary, knocking down FAST1 had the opposite effects. Mechanistically, The TGF-β/Smad pathway contributed to RC evolvement and was activated by FAST1 both in vitro and in vivo. CONCLUSION: This article suggests that FAST1 exerts a carcinogenic role in RC by regulating the TGF-β/Smad signaling.
PURPOSE: Renal carcinoma (RC) originates in the renal tubular epithelial system, among which renal cell carcinoma (RCC) is the most frequent one. The forkhead activin signal transducer 1 (FAST1) has been shown to interfere with tumor progression as an oncogene, while its role in RC is limited. Therefore, this paper explored the prognostic significance, specific effects, and related mechanisms of FAST1 on RC. PATIENTS AND METHODS: Cell colony formation assay, cell counting kit-8 (CCK8) assay, flow cytometry and Transwell assay were used to test cell proliferation, viability, apoptosis, migration and invasion, respectively. Western blot (WB) was employed to determine the protein level of FAST1. RESULTS: Our study confirmed that FAST1 was up-regulated in RC tissues and cell lines, and its overexpression often represented a poor prognosis of RC patients. Meanwhile, the in vitro experiments showed that overexpressing FAST1 facilitated RC cell viability, proliferation, migration, invasion and epithelial-mesenchymal transition (EMT), and repressed cell apoptosis. In addition, the in vivo experiments illustrated that the up-regulation of FAST1 strengthened tumor growth. On the contrary, knocking down FAST1 had the opposite effects. Mechanistically, The TGF-β/Smad pathway contributed to RC evolvement and was activated by FAST1 both in vitro and in vivo. CONCLUSION: This article suggests that FAST1 exerts a carcinogenic role in RC by regulating the TGF-β/Smad signaling.
Authors: Chun-Xiao Huang; Nan Chen; Xin-Jie Wu; Yan He; Cui-Hong Huang; Hong Liu; Wei-Min Wang; Huan-Ling Wang Journal: Life Sci Date: 2017-01-08 Impact factor: 5.037
Authors: R H Rouce; H Shaim; T Sekine; G Weber; B Ballard; S Ku; C Barese; V Murali; M-F Wu; H Liu; E J Shpall; C M Bollard; K R Rabin; K Rezvani Journal: Leukemia Date: 2015-12-01 Impact factor: 11.528
Authors: Tony Navas; Thomas D Pfister; Simona Colantonio; Amina Aziz; Lynda Dieckman; Richard G Saul; Jan Kaczmarczyk; Suzanne Borgel; Sergio Y Alcoser; Melinda G Hollingshead; Young H Lee; Donald P Bottaro; Tara Hiltke; Gordon Whiteley; Naoko Takebe; Robert J Kinders; Ralph E Parchment; Joseph E Tomaszewski; James H Doroshow Journal: PLoS One Date: 2018-06-21 Impact factor: 3.240